Publications by authors named "Samuel Ramage"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,515

Total Likes

271

Extended Reach

1,473,841

Social Features

146
C
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M Waszak, Stefan R Sweha, Mateus Mota, Matthew Pun, Akash Deogharkar, Chan Chung, Rohinton S Tarapore

Cancer Discov· November 2023

Videos about Article: user user

2 144 3 80

View All Article and Social Media Activity
P
Prognostic Features of Recurrent Midline and H3 K27M-Mutant Glioma.
Stephen J Bagley, Yoshie Umemura, Joe S Mendez, Isabel Arrillaga-Romany, Kevin J Bielamowicz, Samuel C Ramage

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M Waszak, Stefan R Sweha, Samuel Ramage

Cancer Discov· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
Isabel Arrillaga-Romany, Sharon L Gardner, Yazmin Odia, Dolly Aguilera, Joshua E Allen, Samuel C Ramage

J Clin Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort.
Yazmin Odia, Matthew D Hall, Timothy Francis Cloughesy, Patrick Y Wen, Isabel Arrillaga-Romany, Samuel C Ramage

Neuro Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.
Yazmin Odia, Carl Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera, Samuel C Ramage

Neuro Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Management of Olaratumab Infusion-Related Reactions.
Brian A Van Tine, Rangaswamy Govindarajan, Steven Attia, Neeta Somaiah, Scott S Barker, Samuel C Ramage

J Oncol Pract· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of alpha/beta-androstenediol immune regulating hormones on bone remodeling and apoptosis in osteoblasts.
Nicole H Urban, Brett Chamberlin, Samuel Ramage, Zachary Roberts, Roger M Loria

J Steroid Biochem Mol Biol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of RANKL in osteolytic membranes: association with fibroblastic cell markers.
Samuel C Ramage, Nicole H Urban, William A Jiranek, Aparna Maiti, Matthew J Beckman

J Bone Joint Surg Am· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-reactive protein inhibits in vitro oxidation of low-density lipoprotein.
Miguel L Rufail, Samuel C Ramage, Rik van Antwerpen

FEBS Lett· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis